Multimodality vendor Picker Internationalmay be a potential suitor for x-ray and mammography vendor Gendex,which was put on the block last month by owner Dentsply International(SCAN 10/26/94). Picker is "interested" in Gendex, accordingto
Multimodality vendor Picker Internationalmay be a potential suitor for x-ray and mammography vendor Gendex,which was put on the block last month by owner Dentsply International(SCAN 10/26/94). Picker is "interested" in Gendex, accordingto spokesperson Mike Peterson. He declined to elaborate further.
Dentsply announced in October that it plans to divest its medicaloperations and focus on its core dental business. Dentsply signedan agreement to sell x-ray tube manufacturer Eureka X-Ray Tubeto Varian Associates.
In other Picker news, the Cleveland vendor announced that ithas acquired the manufacturing and distribution rights to KubotaGraphics' Denali 3-D graphics processor. The processor is integratedwith Digital Equipment's Alpha hardware in Picker's Odyssey VPnuclear medicine workstation. The acquisition should improve Picker'sposition in complex 3-D display, particularly in nuclear cardiologyapplications, according to the company.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.